# Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)

> **NCT02433613** · — · COMPLETED · sponsor: **Medtronic Cardiac Ablation Solutions** · enrollment: 1071 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02433613
- **Lead sponsor:** Medtronic Cardiac Ablation Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2018-11-20
- **Final completion:** 2019-05
- **Target enrollment:** 1071 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433613, "Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02433613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*